Altos Labs

Restoring cell health and resilience

San Francisco, United States · Founded 2021 · $3.0B raised

Employees
501–1000
Founded
2021
Business Model
B2B
Total Funding
$3.0B
Last Round
Series AJan 2022
Rounds
1

About

Altos Labs is a biotechnology company pursuing cellular rejuvenation programming to restore cell health and resilience, with the aim of reversing disease, injury, and the disabilities that can occur throughout life. Building on Nobel Prize-winning research in cellular reprogramming, Altos operates research institutes in the San Francisco Bay Area, San Diego, and Cambridge (UK). It launched in 2022 with roughly $3 billion in initial funding from investors including ARCH Venture Partners, Jeff Bezos, and Yuri Milner, making it one of the best-funded biotech startups ever.

Summary

Altos Labs is a Life Sciences company based in San Francisco, United States, founded in 2021. It has raised $3.0B in total across 1 round, most recently a Series A round in Jan 2022. Investors include Jeff Bezos, Yuri Milner and ARCH Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Funding History

Series AJan 2022

Investors

Similar Companies